Baker McKenzie Rechtsanwälte LLP & Co KG advises buyers and sellers from an array of sectors, including energy, pharma, financial, and IT, on international M&A deals, and is particularly recommended for transaction that involve multiple jurisdictions. Leading the department alongside Gerhard Hermann, Eva-Maria Ségur-Cabanac ‘s areas of expertise include ESG-related instructions, whereas Hermann is well regarded for proficiency in corporate governance matters and private equity transactions.
L’éditorial du Legal 500

Témoignages

Collectés indépendamment par l'équipe de recherche du Legal 500.

  • ‘I appreciate the responsiveness of this team, their deep understanding of our business and their excellent problem-solving and service-orientated approach.'

  • ‘The team has a great expertise in corporate and M&A. It´s a young and motivated team, managing the case closely. Cooperation within the team and with experts across the fields of expertise within their organization works perfectly fine.'

  • 'Philipp Stanek is very responsive, easy to reach and proactive.'

  • ‘Very aware of dynamics in the Austrian and CEE M&A market, extremely proactive and commercially sensitive.’

  • ‘Embedded in a global organization, therefore aware of global dynamics and trends together with market-leading awareness of Austrian and CEE M&A trends and market.'

  • ‘Combined expertise, highly-skilled, quick response.’

  • ‘Gerhard Hermann is a distinguished expert on corporate law and M&A transactions. He is always available, provides excellent advice, and drafting and has a huge experience.'

  • ‘Gerhard Hermann has an excellent knowledge of the law, is extremely co-operative and creative to enable deals to be completed. He is also a very likeable person and very strong in negotiations.’

Clients clés

  • Accenture
  • ATOS SE
  • Baxter International Inc.
  • Burgenland Energie
  • Colt Technology Services
  • Delachaux S.A.
  • FCC
  • GATX Corporation
  • GlaxoSmithKline
  • Haier Smart Home

Points forts

  • Advised Kudelski Group on the sale of SKIDATA.
  • Advised the shareholders of an Austrian biotech company on the sale of their shares in APEIRON Biologics AG to Ligand Pharmaceuticals Incorporated for $100m.  
  • Advised Paris stock exchange-listed ATOS on a carve-out, including demergers, share sales and business transfers.

Avocats

Responsable de la pratique

Gerhard Hermann; Eva-Maria Ségur-Cabanac

Autres avocats clés

Philipp Stanek; Sophie Schubert